.svg){kind=small}
.svg)
Enquiry Form
Please would you tell us about the nature of your enquiry send. if your enquiry is the provision of our service conducting clinical trials we will get back to you by telephone or email as soon as possible.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Telephone:
+44 (0) 20 7042 5800
HQ Address:
1a Newcomen Street
London Bridge
London
SE1 1YR
London Bridge
London
SE1 1YR
.avif)
Spoken Languages
English, French, German and Japanese
Socials
.avif)
Latest news
Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1
March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read moreEvents
Clinical Trials Innovation Programme
10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event
